Photo of Tarvez Tucker, M.D.

Tarvez Tucker M.D.

Dr. Tucker specializes in:

  •     Neurocritical care
  •     Traumatic brain Injury
  •     Headache and pain management
  •     Hypothermia after cardiac arrest


As a neurologist at the OHSU Brain Institute, Dr. Tucker joins the neurocritical care team as a neurointensivist in the neuroscience intensive care unit. Dr. Tucker will work with OHSU’s neurologists and other specialists collaborating on patient evaluations and treatment options to ensure quality care.

Education

  • B.A., Oberlin College, Oberlin Ohio 0
  • Residency:

    • Medicine, neurology, University of California
  • Fellowship:

    • Neurocritical care, University of Cincinati
  • Certifications:

    • American Board of Psychiatry and Neurology

Publications

  • "Subacute, reversible motor neuron disease" Neurology  1991
  • "Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome" Annals of Neurology  1985
  • "Single-Site Botulinum Toxin Type A Injection for Elimination of Migraine Trigger Points" Headache November 2003
  • "Central nervous system AIDS" Journal of the Neurological Sciences  1989
  • "Botulinum toxin A and migraine surgery" Plastic and Reconstructive Surgery October 2003
  • "Maculopathy in spinocerebellar ataxia type 7" Neurology July 13 1999
  • "A practical approach to headache treatment" Journal of Pharmacy Practice April 2007
  • "Hourglass Deformity after Botulinum Toxin Type A Injection" Headache March 2004
  • "Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy" Neurology October 9 2001
  • "Surgical treatment of migraine headaches" Plastic and Reconstructive Surgery  2002
  • "A phase I/II trial of nimodipine for HIV-related neurologic complications" Neurology July 1998
  • "A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection" Neurology December 1998
  • "Induction of Progressive Profound Hypocitraturia with Increasing Doses of Topiramate" Urology July 2008
  • "Re" Neurology  1992
  • "A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection" Neurology March 14 2000
  • "Stable neurological function in subjects treated with 2'3'dideoxyinosine" Journal of NeuroVirology June 1997

Additional information

Edit profile